Urinary biomarkers for obstructive sleep apnea syndrome: Lipocalin type prostaglandin-D synthase and F2-isoprostane Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Oral nitric oxide in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Increased alveolar nitric oxide by trumpet model in patients with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007
Nitric oxide in airways of patients with obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
Nitric oxide and obstructive sleep apnea syndrome (OSAS): reflection of inflammation and oxidative stress Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Vitamin D deficiency and excessive daytime sleepiness in obstructive sleep apnea: Is there a correlation? Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Serum vitamin D levels are associated with markers of hypoxia in obstructive sleep apnea patients Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
The role of vitamin D in obstructive sleep apnoea syndrome Source: Breathe, 14 (3) 206; 10.1183/20734735.000618 Year: 2018
Concentration of exhaled nitric oxide (FENO ) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003
Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
impact of continous positive airway pressure therapy on exhaled nitic oxide in obstructive sleep apnea syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019